A comparison of a combination of penbutolol and frusemide with the two compounds individually in the treatment of hypertension.

British Journal of Clinical Pharmacology

Volumn 16, Issue 5, 1983, Pages 561-564

  Chadha, DR ^a   Houtzagers, JJ ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; PENBUTOLOL; PLACEBO;

CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG MIXTURE; DRUG THERAPY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THERAPY;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FUROSEMIDE; HUMAN; HYPERTENSION; MIDDLE AGE; PENBUTOLOL; PROPANOLAMINES; RANDOM ALLOCATION;

EID: 0021027888     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1983.tb02217.x     Document Type: Article

References (10)

1. The role of randomization in clinical trial.
2. β‐adrenoceptor blocking drugs and diuretics in hypertension.
3. The abrupt discontinuation of anti‐hypertensive treatment.
4. Clinical experience with a fixed dose combination of penbutolol and furosemide in hypertension.
5. Use of fixed doses of beta‐blocking drugs in the treatment of hypertension.
6. Penbutolol and furosemide in a fixed dose combination–‐bio‐equivalence of two formulations.
7. Multi‐clinic double‐blind evaluation of timolol combined with hydrochlorothiazide in essential hypertension.
8. Metoprolol withdrawal phenomena–‐mechanism and prevention.
9. Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension.
10. Propranolol in the treatment of essential hypertension.